LGALS3BP and cancer: Elevated expression of the tumor-associated glycoprotein, galectin 3 binding protein (LGALS3BP, formerly 90K and MAC-2-BP), has been reported in various types of cancer, including pancreatic [144], gastric [145], and colon cancer [146], and the expression of LGALS3BP has been shown to be associated with poor prognosis in colon cancer [146, 147].